Results 41 to 50 of about 2,024,265 (255)

Bleeding on oral anticoagulants: overview of reversal strategies

Swiss Medical Weekly, 2023
Oral anticoagulants (antivitamin K, direct oral anticoagulants) are routinely prescribed for the prevention or treatment of thromboembolic events, and many patients are now on long-term anticoagulant therapy.
Mauro Foletti, Thomas Schmutz, Yvan Fleury, Jean-Luc Magnin, Christophe Le Terrier, Youcef Guechi   +5 more
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source

Anticoagulant-induced oral bleeding

Brazilian Dental Science, 2017
Warfarin is an anticoagulant used to prevent thrombosis, cardiac arrhythmias, atrial fibrillation, and recurrence of pulmonary embolism. A 69-year-old male patient reported episodes of four heart attacks, stroke, pulmonary emphysema, varicose veins ...
Victor Costa, Estela Kaminagakura
doaj   +1 more source

Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring [PDF]

, 2020
Introduction: Portal venous thrombosis is a life-threatening cause of abdominal pain. In younger patients, heritable thrombophilias, pregnancy, tobacco use, and oral contraceptives are associated.Case Report: A 26-year-old woman prescribed contraceptive ...
Bailey, Katelynn E., Tranovich, Michael J.   +1 more
core  

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use

CJC Open, 2023
Background: For patients with atrial fibrillation who have an ischemic stroke or transient ischemic attack (TIA) despite taking direct oral anticoagulants (DOACs), the optimal strategy for ongoing anticoagulation is unknown.
Eric Duong, BSc, MSc, PharmD, Mu Lin, PhD, Mathew Hodgson, BSP, Glen Jickling, MD, MSc, FRCPC, Kirsten George-Phillips, BSP, Tammy J. Bungard, BSP, PharmD   +5 more
doaj   +1 more source

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE

Malang Neurology Journal, 2023
Background: Cardioembolic stroke is a category of ischemic stroke that manifests more severe, is prone to recurrence, and is related to a higher mortality rate than the other categories of ischemic stroke.
Reihan Achmad Reza, Lisda Amalia, Nushrotul Lailiyya Dahlan, Cep Juli, Hanna Goenawan   +4 more
doaj   +1 more source

Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) [PDF]

, 2016
Introduction: Atrial fibrillation is an independent risk factor of thromboembolism. Women with atrial fibrillation are at a higher overall risk for stroke compared to men with atrial fibrillation. The aim of this study was to evaluate for sex differences
Abdul-Rahim, Azmil, Acciarresi, Monica, Ageno, Walter, Agnelli, Giancarlo, Akhtar, Naveed, Alberti, Andrea, Antonenko, Kateryna, Baldi, Antonio, Barlinn, Kristian, Baronello, Mario M., Becattini, Cecilia, Bodechtel, Ulf, Bono, Giorgio, Bovi, Paolo, Carletti, Monica, Carolei, Antonio, Caso, Valeria, Chiti, Alberto, Consoli, Domenico, Cordier, Maria, Corea, Francesco, Csiba, Laszló, De Lodovici, Maria Luisa, Del Sette, Massimo, Deleu, Dirk, Denti, Licia, Doronin, Boris, D’Amore, Cataldo, D’Anna, Antonio, Falocci, Nicola, Galati, Franco, Gerber, Johannes, Gialdini, Gino, Guideri, Francesca, Ibrahim, Faisal, Imberti, Davide, Kepplinger, Jessica, Lees, Kennedy R., Lorenzini, Gianni, Marcheselli, Simona, Martini, Giuseppe, Masotti, Luca, Melikyan, Gayane, Michel, Patrik, Monaco, Serena, Mosconi, Maria G., Orlandi, Giovanni, Paciaroni, Maurizio, Padovani, Alessandro, Pallesen, Lars-Peder, Papageorgiou, Sokratis G., Pezzini, Alessandro, Pieroni, Alessio, Poli, Loris, Putaala, Jukka, Remillard, Suzette, Rigatelli, Alberto, Rueckert, Christina, Sacco, Simona, Scoditti, Umberto, Sohn, Sung-Il, Szabó6, Lilla, Tassi, Rossana, Tassinari, Tiziana, Tatlisumak, Turgut, Tiseo, Cindy, Toni, Danilo, Tsivgoulis, Georgios, Vadik, Kostantinos, Vanacker, Peter, Venti, Michele, Volodina, Vera, Zabzuni, Dorjan   +72 more
core   +1 more source

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]

, 2018
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M, Hirsh J, Ibanez B, Mega JL, Park KW, Suh JW, Valgimigli M   +6 more
core   +3 more sources

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review

Российский кардиологический журнал, 2023
The review article discusses the issues of anticoagulant therapy in cardiovascular patients with thrombocytopenia (TP), gives the concept of ethylenediaminetetraacetic acidand heparin-induced TP.
K. G. Pereverzeva, S. S. Yakushin, A. An. Korshikova   +2 more
doaj   +1 more source

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study

British Journal of Clinical Pharmacology, 2019
To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 European healthcare databases representing 6 European countries.
L. Ibáñez, M. Sabaté, X. Vidal, E. Ballarín, M. Rottenkolber, S. Schmiedl, Andreas Heeke, C. Huerta, Elisa Martín Merino, D. Montero, L. León-Muñoz, C. Gasse, N. Moore, C. Droz, R. Lassalle, M. Aakjær, M. Andersen, M. D. De Bruin, R. Groenwold, H. A. Ham, P. Souverein, O. Klungel, H. Gardarsdottir   +22 more
semanticscholar   +1 more source